Michael Cook to retire from Lilly's board of directors
This article was originally published in Scrip
Michael Cook is to retire from Lilly's board on April 20th. Mr Cook, the retired chairman and CEO of Deloitte & Touche, has been a director on the Lilly board since 2005. He has also been a member of both the compensation and finance committees, and has served as chair of the audit committee since 2006. Michael Eskew, the retired chairman and CEO of United Parcel Service, will replace Mr Cook as chair of the audit committee. He has been a member of Lilly's board since 2008 and has served on both the audit and compensation committees.
You may also be interested in...
FDA's COVID-19 Naughty List Now Includes Marketers Of Copper Germ Stoppers, ‘24-Hour’ Hand Sanitizer
Warning letters issued by the US FDA on 28 May target two companies using COVID-19 and other disease-prevention claims to market purported germ-killing products, including a rub touted as 24-hour protection and a line of copper rollers and other implements to disinfect hands and personal items.
Industry-funded survey by Charles River Associates explores diverse perceptions about pricing for high-cost cell treatments – including curative cell and gene therapy – among various stakeholder groups.
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.